Globus Medical Inc. Class A Common Stock vs Illinois Tool Works Inc. — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.85 (market cap $10.25B), while Illinois Tool Works Inc. trades at $271.62 (market cap $76.75B). The key difference: Illinois Tool Works Inc. is far larger — about 7.5× Globus Medical Inc. Class A Common Stock's market cap, and Illinois Tool Works Inc. pays a 2.55% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Illinois Tool Works Inc. for 66 Days on average.
| GMED | ITW | |
|---|---|---|
Market Cap | $10.25B | $76.75B |
Volume | 1,059,528 | 1,222,646 |
Sector | Health | Industrials |
52-Week High | $96.82 | $299.60 |
52-Week Low | $58.33 | $241.07 |
Typical Hold Time | 0 Days | 66 Days |
Enterprise Value | $9.76B | $85.60B |
Dividend Yield | — | 2.55% |
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
ITW trades at $266.32, up 0.46% today, with a bearish technical signal but strong fundamentals including a 19.39% net income margin and consistent earnings beats. The stock is supported by a recent dividend raise to $1.72 and positive analyst upgrades, though it faces headwinds in automotive and foodservice segments. Cash flow trends show stable operations, with 2026 net cash flow projected at $51 million.
Outlook is mixed: valuation metrics like P/E of 24.12 are reasonable for a Dividend King with 59 years of increases, but high debt-to-asset ratio of 55.54% and bearish technicals pose risks. Upside to the $276.86 consensus price target depends on sustaining organic growth amid sector weaknesses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →Illinois Tool Works is a diversified global manufacturer that produces specialized industrial equipment, consumables, and related services. The firm operates 87 global divisions through seven distinct operating segments: automotive OEM, construction products, food equipment, specialty products, test/measurement and electronics, polymers and fluids, and welding. About half of its revenue comes from its operations in North America, with the remainder originating from international markets. ITW takes a bottom-up and decentralized approach to portfolio management, with the exception that each segment must apply its 80/20 operating process modeled on the Pareto principle.
Read more on ITW →